Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The nucleotide sequence of the Shigella boydii dgt gene, which encodes the enzyme
deoxyguanosine triphosphate triphosphohydrolase
(
dGTPase
,
EC 3.1.5.1
), has been determined. The 1515-nucleotide Shigella dgt open reading frame has been subcloned into a T7
RNA polymerase
-based expression vector. The resulting expressed protein has been purified to homogeneity using a novel single-day chromatographic regime. The protocol includes ion exchange, affinity, and hydrophobic interaction chromatography. The purified 505-amino acid (59.4 kDa) protein exists in solution as a heat-stable homotetramer, and enzymatic assays reveal that the expressed enzyme is fully active. Substrate specificity can be explained by the array of potential hydrogen bond donors/acceptors displayed on the base moiety of the (deoxy)nucleoside triphosphate. Shigella
dGTPase
can be inhibited by the addition of stoichiometric amounts of reducing agents. The loss of activity is both time- and concentration-dependent and is accompanied by a decrease in the thermal stability of the enzyme. Shigella
dGTPase
in the fully reduced form is destabilized by 1.8 kcal/mol compared with the oxidized form. Hence, disulfide bonds play a pivotal role in the maintenance of
dGTPase
stability and enzymatic functionality. Initial Shigella
dGTPase
protein crystals have been formed.
...
PMID:Cloning, purification, and characterization of the Shigella boydii dGTP triphosphohydrolase. 899 66